Le Lézard
Classified in: Health
Subjects: PDT, PET

BPTS Launches Veterinary Pharmacy Certificate


New credential recognizes pharmacy technicians providing pharmaceutical care to animals.

HOUSTON, Nov. 1, 2023 /PRNewswire/ -- The Board of Pharmacy Technician Specialties (BPTS), the nation's most affordable and accessible credentialing organization for pharmacy technicians, is launching a Veterinary Pharmacy Certificate. This specialized credential will be the first of its kind to recognize pharmacy technicians involved in providing pharmaceutical care for animals.

"We are excited to provide pharmacy technicians with a unique opportunity to distinguish themselves and their specialized knowledge as it relates to veterinary prescriptions," said BPTS Founder & CEO Mike Johnston. "Many pharmacy technicians play a critical role in providing veterinary pharmaceutical care and now they can be recognized for doing so."

Candidates must be an active CPhT (through either NHA or PTCB) and either complete a BPTS-Recognized Training Program for Veterinary Pharmacy or have completed 1 year or 1,000 hours of supervised pharmacy experience related to veterinary prescriptions. BPTS has already approved the Veterinary Pharmacy Certificate Program for Pharmacy Technicians offered by PowerPak, an industry leader in continuing pharmacy education programs. More information about the course can be found at https://www.powerpak.com/vetpt/

"We are thrilled to join with BPTS in this endeavor to be a BPTS-Recognized Training Program for their Veterinary Pharmacy Certificate," said Susanne Batesko, President at PowerPak. "By working together, we can foster continued learning and growth within the pharmacy technician community."

The Veterinary Pharmacy Certificate marks the fifteenth credential to be offered by BPTS, amongst their extensive specialty assessment-based certificates, CPhT-Adv certification, and Board Certifications in Sterile Compounding and Non-Sterile Compounding. To learn more, visit www.bpts.org

Media Contact:
Ashleigh Smith
[email protected]
888-230-3904

SOURCE Board of Pharmacy Technician Specialties (BPTS)


These press releases may also interest you

at 18:05
Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 14:06
Red Door Community Raises more than $300,000 at Their Annual Luncheon Celebrating Women Working and Living with Cancer
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Easy Eats Pandemanila brand Kalihim (Philippine Bread Rolls) recalled due to undeclared egg
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
Industrial Automation Market In Life Sciences Industry size is set to grow by USD 5.06 bn from 2024-2028, growing global demand for healthcare services to boost the market growth, Technavio
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
MODULAR ATP Study of the mCRMtm System Meets Primary Safety and Efficacy Endpoints
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

More news about Health...


News published on and distributed by: